Solid Biosciences (SLDB)
NASDAQ:SLDB
US Market
Holding SLDB?
Track your performance easily

Solid Biosciences (SLDB) Income Statement

555 Followers

Solid Biosciences Income Statement

Last quarter (Q2 2024), Solid Biosciences's total revenue was $300.00K, an increase of Infinity% from the same quarter last year. In Q2, Solid Biosciences's net income was $-25.07M. See Solid Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 300.00K-$ 8.09M$ 13.62M$ 0.00$ 0.00
Cost of Revenue
--$ 1.47M$ -777.00K--
Gross Profit
$ 300.00K-$ 8.09M$ 13.62M--
Operating Expense
$ 100.03M$ 104.31M$ 114.55M$ 85.87M$ 86.46M$ 119.32M
Operating Income
$ -100.03M$ -104.25M$ -106.45M$ -72.25M$ -86.46M$ -119.32M
Net Non Operating Interest Income Expense
$ 8.55M$ 7.14M$ 2.62M$ 64.00K$ 115.00K$ 1.58M
Other Income Expense
$ -790.00K$ 1.16M$ -17.86M$ -2.00K$ -1.94M$ 515.00K
Pretax Income
$ -90.69M$ -96.02M$ -85.98M$ -72.19M$ -88.29M$ -117.22M
Tax Provision
---$ 0.00--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -90.69M$ -96.02M$ -85.98M$ -72.19M$ -88.29M$ -117.22M
Basic EPS
$ -3.30$ -4.83$ -10.10$ 0.00$ -1.70$ -2.91
Diluted EPS
$ -3.30$ -4.83$ -10.10$ -10.20$ -1.70$ -2.91
Basic Average Shares
$ 119.39M$ 19.88M$ 8.51M$ 7.12M$ 51.94M$ 40.29M
Diluted Average Shares
$ 119.39M$ 19.88M$ 8.51M$ 7.12M$ 51.94M$ 40.29M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 100.03M$ 104.31M$ 116.02M$ 85.10M$ 86.46M$ 119.32M
Net Income From Continuing And Discontinued Operation
$ -90.69M$ -96.02M$ -85.98M$ -72.19M$ -88.29M$ -117.22M
Normalized Income
$ -57.46M$ -75.54M$ -60.75M-$ -86.35M$ -117.74M
Interest Expense
------
EBIT
$ -92.44M$ -104.31M$ -85.98M$ -72.25M$ -86.46M$ -119.32M
EBITDA
$ -90.52M$ -101.73M$ -83.34M$ -68.17M$ -82.54M$ -116.49M
Currency in USD

Solid Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis